Today: 14 July 2026
BlackBerry Stock Has a New Test: Can QNX Carry the AI Robotics Bet?

BlackBerry Stock Has a New Test: Can QNX Carry the AI Robotics Bet?

Waterloo, Ontario, May 7, 2026, 10:02 EDT

BlackBerry’s QNX division plans to spotlight its software at a Boston robotics conference later this month, aiming to highlight its potential uses beyond autos—think AI-powered robots, medical devices, and factory systems. On May 6, the unit announced it would deliver live demos, present a keynote, and unveil new research during the Robotics Summit & Expo, set for May 27-28. For BlackBerry, it’s another signal of its shift away from smartphones.

The timing is crucial here, with BlackBerry stock experiencing a swift revaluation. The U.S.-listed shares slipped about 1.3% in early New York action, last trading at $5.91. Earlier in the session, they reached as high as $6.19, following a run-up that briefly pushed the company’s market cap close to $3.5 billion.

Forget the legacy phone image—QNX is what’s catching investor attention now. That real-time operating system, designed for ultra-fast machine response, has become the story. BlackBerry shares jumped over 5% Monday, following a Wall Street Journal piece spotlighting QNX’s momentum. According to Investopedia, the stock was up more than 50% for the year at that point.

QNX plans to demo robotic arms, digital factory setups, and motion-replication tools, all powered by Intel and NVIDIA gear. It’s aiming to highlight what it calls “deterministic” control—basically, machines that respond in predictable ways—as artificial intelligence shifts beyond digital displays or simulations to real-world hardware. Nasdaq

“Robotics is at an inflection point,” QNX Chief Marketing Officer Carsten Hurasky said in the release. For him, it’s all about risk: “the safety stakes are incredibly high” when AI-powered systems are working around people. That’s the pitch at this stage—not just chatbot hype, but machine software where mistakes have real-world consequences. Nasdaq

BlackBerry’s push has been ongoing for weeks. In April, QNX announced it was deepening work with NVIDIA to bring QNX OS for Safety 8.0 together with NVIDIA’s IGX Thor and Halos safety stack, aiming at robotics, medical tech, and industrial systems. “Safety and determinism cannot be afterthoughts,” said QNX President John Wall. Newswire

Competition is heating up. Wall is set to speak alongside execs from Amazon Robotics, Locus Robotics, and Universal Robots in the Robotics Summit’s opening keynote on robot autonomy—BlackBerry’s software team now sharing a stage with firms pushing large-scale automation.

The rally caught a lift from BlackBerry’s latest earnings. As Reuters noted on April 9, QNX revenue jumped 20% to $78.7 million in the fourth quarter, and the unit’s royalty backlog swelled to roughly $950 million. For the first quarter, BlackBerry is projecting revenue between $132 million and $140 million — clear of the $129.9 million average analyst estimate from LSEG.

Chief Executive John Giamatteo described the business to Reuters as being centered on “regulated, complex, mission-critical solutions”—that’s the logic behind BlackBerry steering QNX toward robotics and medical systems rather than mass-market AI software. CFO Tim Foote added the company intends to increase spending on QNX sales and marketing, targeting physical AI, robotics, and medical uses. Reuters

The story comes with real risk. In its annual report, BlackBerry flagged steep competition for QNX, calling out embedded software rivals and open-source Linux. The company noted that competitors could outpace QNX, undercut on price, or exploit bigger customer rosters to grab market share.

The company noted that QNX revenue often gets pushed back, depending on when software-defined vehicle projects ramp up and when production begins at both auto and embedded-market clients. That’s significant: showing off robotics demos can stir up investor excitement fast, but actually turning those design wins into real revenue tends to take longer.

Right now, it’s all about execution for BlackBerry. Investors have the stock’s rally, the NVIDIA partnership and a QNX backlog on their side. But the question remains: can robots, medical devices, and factory systems actually grow beyond just being an add-on to BlackBerry’s automotive software business?

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • NextCure Jumps 176.6% After Announcing Avere Deal, Financing Terms
    July 14, 2026, 12:18 PM EDT. NextCure jumped 176.6% to $6.03 after the company said it would merge with Avere Therapeutics and line up $320 million in financing. Most of that, $251 million or 78%, is coming from notes converted to shares instead of new capital. Existing holders will see their stake cut to 1.21% from 1.89% after cash steps, which puts a lower value on NextCure in the deal. The run is about bets on possible cash payouts and contingent-value rights plus bringing Avere public, not the headline funding size. About 81.4 million shares changed hands, nearly 20x shares outstanding, as traders moved on the news.
CDW Corporation Stock Plunges 20% After Revenue Beat Exposes AI Margin Squeeze
Previous Story

CDW Corporation Stock Plunges 20% After Revenue Beat Exposes AI Margin Squeeze

Fidelity Layoffs 2026: 800 Jobs Cut As Boston Firm Rebuilds Tech Teams And Hires Thousands
Next Story

Fidelity Layoffs 2026: 800 Jobs Cut As Boston Firm Rebuilds Tech Teams And Hires Thousands

Go toTop